The great NHS prescribing lottery. Imagine a patient in Manchester receiving a cutting-edge medication, while another in Cornwall waits endlessly for the same treatment. Welcome to the NHS prescribing landscape, where geography can influence therapy as much as pathology.
Here at HSJ Information, we’ve delved into this conundrum using our exclusive specialist share data, which looks at actual patient numbers on a specified medicine by Trust, cancer alliance, ICB or other footprint, rather than script numbers.
The findings? A tapestry of inconsistencies that raise eyebrows and questions in equal measure. In this article, I will first show how those variations play out in the figures, then explore why, and finally discuss what can be done about it: with the right data; the right analysis; the right strategy; the right engagement and the help of advanced segmentation tools.
Check out the rest of the feature here
